Tag Archives: United States Congress

Waxman Retirement, Tip of the Iceberg

The Washington health policy world is headed for a major shake-up next year, as more long-time leading legislators opt for retirement. The recent announcement that Rep. Henry Waxman (D-Calif) will leave marks the end of a 40-year career on Capitol Hill, highlighted by engineering enactment of legislation that established the generic drug industry, supported treatment […]
Posted in FDA, healthcare, People, Regulatory, Strategy | Also tagged , | Leave a comment

Sequestration: How Big a Hit for FDA, Research and Pharma?

The greatly feared federal budget sequestration mandate went into effect March 1, and, initially, the impact was fairly muted. The stock market soared, employment rose and government workers continued on their jobs. Federal agencies, including the Food and Drug Administration (FDA), launched initiatives to comply with the mandated 5% across-the-board cut in spending (in reality […]
Posted in FDA, healthcare, leadership, Legal, R&D | Also tagged , , , , , , | Leave a comment

Elmendorf Refuses to Go Quietly Into the Night of HCR

Guest Blog by Tom Norton of NHD Smart Communications. You can reach him at tnorton@nhdcomm.com. Amidst all the gurgling of oil last week(bad! bad! bad!), a competing thunderstorm of words erupted as Doug Elmendorf, Director of CBO, had the temerity to revisit the real costs of the new HCR law. Addressing something that, for whatever […]
Posted in Guest Blog | Also tagged , , , , , , | 2 Comments

PhRMA’s Tauzin Calls it a Day

PhrMA President and CEO Billy Tauzin announced on Friday that he will step down from his post after five years with the pharmaceutical lobby group. The move comes amid speculation that the President’s healthcare reform bill has stalled in Congress thanks in part to the recent Republican Senate win in Massachusetts. Tauzin was an integral […]
Posted in People | Also tagged , , , , | Leave a comment

Health Reform Hazards: Steering Your Course Through the Rhetorical Shallows

Image by Getty Images via Dayli Crafting consensus legislation on health reform depends heavily on all parties understanding precisely the terms of the debate. With the two House and Senate bills now topping out at more than 4,000 text pages, prospects for even a basic awareness of the implications of this reform for big pharma […]
Posted in FDA, News | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta